close

Driving health and growth in Europe: European pharmaceutical trade body EFPIA sparks discussion with #HealthyEU conference

(15 October 2014 – Brussels): EFPIA is pleased to announce the successful conclusion of its first #HealthyEU Conference: Health Driving Growth in Europe. The aim of the event was to advance the conversation for boosting health and economic growth for Europe. 

EFPIA President and Sanofi CEO, Chris Viehbacher, provided opening remarks, emphasising the importance of the event’s mission: “Health has the potential to serve as a key enabler of a productive European economy. The programme of President-elect Jean-Claude Juncker “A new start for Europe” offers a compelling vision for the future and a renewed call for partnership between Union institutions and Member States. The European biopharmaceutical industry, which invests over 30 billion Euros per year in R&D and is one of Europe’s largest exporters, can support a new start for Europe through a strong contribution to the health of Europeans and to the growth of our European economy.”

Read the full press release here.[1]